0 NYSE Companies - October 9, 2024Northrop Grumman Unveils the Next Generation of Bushmaster® Chain Gun®PLYMOUTH, Minn., Oct. 09, 2024 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC), a leading manufacturer of medium-caliber cannons, is […]Read More
0 Canadian Stock Exchange News - October 9, 2024PTX Metals Appoints Dave Bell as a Technical Advisor to Its 100% Owned W2 Copper, Nickel, PGE and Gold ProjectTORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) — PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a […]Read More
0 NASDAQ Companies - October 9, 2024StepStone Private Wealth Surpasses $5 Billion in AUM MilestoneNEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — StepStone Private Wealth (“SPW”) today announced it has surpassed $5 billion in […]Read More
0 NASDAQ Companies - October 9, 2024VCI Global Unleashes Enterprise AI Solutions with V-Gallant, Leveraging NVIDIA’s Computing InfrastructureKUALA LUMPUR, Malaysia, Oct. 09, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global” or the […]Read More
0 NASDAQ Companies - October 9, 2024Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension— Aggregate investment of up to approximately $275 Million by healthcare-focused investment funds, led by Soleus Capital — BOSTON and […]Read More
0 NASDAQ Companies - October 9, 2024Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR SymposiumBERKELEY HEIGHTS, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - October 9, 2024Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy-Company Plans to Complete Rolling BLA Submission by End of 2024; Application May be Eligible for Priority Review by FDA- […]Read More
0 NASDAQ Companies - October 9, 2024La Rosa Holdings Launches My Agent Account Version 3.0 with Enhanced Property Management Disbursement Features; Expected to Enhance La Rosa’s Agents’ Productivity and Efficiency by 50% by Year-EndCelebration, FL, Oct. 09, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding […]Read More